Nov 26, 2018
21:20
For every 20 shares held, investors received 21. The price per share adjusted from $16.90 to $16.10.
The split itself did not change the total investment value.
Central Pharmaceuticals Ltd. (DSE:CENTRALPHL) operates in the Pharmaceuticals: major industry.
Central Pharmaceuticals Ltd. company overviewCentral Pharmaceuticals Ltd.'s most recent stock split was on November 26, 2018. It was a 21-for-20 forward split, so shareholders received 21 shares for every 20 they held.
Central Pharmaceuticals Ltd. (DSE:CENTRALPHL) has split its stock 6 times: a 23-for-20 split on October 29, 2013, a 23-for-20 split on September 30, 2014, a 23-for-20 split on November 23, 2015, a 11-for-10 split on November 21, 2016, a 11-for-10 split on December 4, 2017, and a 21-for-20 split on November 26, 2018.
Central Pharmaceuticals Ltd. has split its stock 6 times. This history records 6 forward splits between October 29, 2013 and November 26, 2018.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Central Pharmaceuticals Ltd.'s 21-for-20 split on November 26, 2018, every 20 shares became 21 shares.
Central Pharmaceuticals Ltd. has not announced a new split in our records. Its most recent split was on November 26, 2018, 7 years ago. Companies announce splits in advance, and any new DSE:CENTRALPHL split will appear on this page.
Already premium?